Related references
Note: Only part of the references are listed.Effects of Long-term Metformin and Lifestyle Interventions on Cardiovascular Events in the Diabetes Prevention Program and Its Outcome Study
Ronald B. Goldberg et al.
CIRCULATION (2022)
Risk Factors for the Development of Retinopathy in Prediabetes and Type 2 Diabetes: The Diabetes Prevention Program Experience
Neil H. White et al.
DIABETES CARE (2022)
Attenuated Risk Association of End-Stage Kidney Disease with Metformin in Type 2 Diabetes with eGFR Categories 1-4
Aimin Yang et al.
PHARMACEUTICALS (2022)
Effect of Metformin and Lifestyle Interventions on Mortality in the Diabetes Prevention Program and Diabetes Prevention Program Outcomes Study
Christine G. Lee et al.
DIABETES CARE (2021)
The Long-term Effects of Metformin on Patients With Type 2 Diabetic Kidney Disease
Soie Kwon et al.
DIABETES CARE (2020)
Long-term Effects of Metformin on Diabetes Prevention: Identification of Subgroups That Benefited Most in the Diabetes Prevention Program and Diabetes Prevention Program Outcomes Study
David M. Nathan et al.
DIABETES CARE (2019)
Progressive Decline in Estimated Glomerular Filtration Rate in Patients With Diabetes After Moderate Loss in Kidney Function-Even Without Albuminuria
Dorte Vistisen et al.
DIABETES CARE (2019)
Does diabetes prevention translate into reduced long-term vascular complications of diabetes?
David M. Nathan et al.
DIABETOLOGIA (2019)
Association of Metformin Use With End-Stage Renal Disease in Patients With Type 2 Diabetes Mellitus: A Nationwide Cohort Study Under the Pay-for-Performance Program
Ming-Chia Lee et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2019)
Effect of metformin on kidney function in patients with type 2 diabetes mellitus and moderate chronic kidney disease
Wei-Hao Hsu et al.
ONCOTARGET (2018)
Renoprotective Effects of Metformin
Marc E. De Broe et al.
NEPHRON (2018)
Impact of Lifestyle and Metformin Interventions on the Risk of Progression to Diabetes and Regression to Normal Glucose Regulation in Overweight or Obese People With Impaired Glucose Regulation
William H. Herman et al.
DIABETES CARE (2017)
Long-term Benefits of Intensive Glucose Control for Preventing End-Stage Kidney Disease: ADVANCE-ON
Muh Geot Wong et al.
DIABETES CARE (2016)
Metformin-associated risk of acute dialysis in patients with type 2 diabetes: A nationwide cohort study
Nicholas Carlson et al.
DIABETES OBESITY & METABOLISM (2016)
Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study
David M. Nathan
LANCET DIABETES & ENDOCRINOLOGY (2015)
Diabetic Kidney Disease: A Report From an ADA Consensus Conference
Katherine R. Tuttle et al.
DIABETES CARE (2014)
Kidney function decline in metformin versus sulfonylurea initiators: assessment of time-dependent contribution of weight, blood pressure, and glycemic control
Adriana M. Hung et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2013)
Comparative effectiveness of incident oral antidiabetic drugs on kidney function
Adriana M. Hung et al.
KIDNEY INTERNATIONAL (2012)
Intensive Diabetes Therapy and Glomerular Filtration Rate in Type 1 Diabetes
Ian H. de Boer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
The Conundrum of Chronic Kidney Disease Classification and End-Stage Renal Risk Prediction in the Elderly - What Is the Right Approach?
Stein Ivar Hallan et al.
NEPHRON CLINICAL PRACTICE (2010)
A New Equation to Estimate Glomerular Filtration Rate
Andrew S. Levey et al.
ANNALS OF INTERNAL MEDICINE (2009)
Changes in Albumin Excretion in the Diabetes Prevention Program
Mark E. Molitch et al.
DIABETES CARE (2009)
Mortality risk stratification in chronic kidney disease: One size for all ages?
Ann M. O'Hare et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
WC Knowler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Share Paper
